Unichem Laboratories Limited (BOM:506690)
India · Delayed Price · Currency is INR 357.50
-4.15 (-1.15%)
At close: May 26, 2026
Unichem Laboratories Market Cap
Unichem Laboratories has a market cap or net worth of 24.89 billion as of May 27, 2026. Its market cap has decreased by -37.73% in one year.
Market Cap
24.89B
Enterprise Value
26.95B
Revenue
22.65B
Ranking
n/a
PE Ratio
9.86
Stock Price
357.50
Market Cap Chart
Since July 30, 2001, Unichem Laboratories's market cap has increased from 5.81B to 24.89B, an increase of 328.64%. That is a compound annual growth rate of 6.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 25.17B | -19.00% |
| Dec 31, 2025 | 31.07B | -40.43% |
| Dec 31, 2024 | 52.16B | 82.07% |
| Dec 29, 2023 | 28.65B | 28.87% |
| Dec 30, 2022 | 22.23B | 27.19% |
| Dec 31, 2021 | 17.48B | -5.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novartis India | 33.64B |
| Bliss GVS Pharma | 31.76B |
| Gufic Biosciences | 29.38B |
| Hikal | 25.28B |
| Morepen Laboratories | 23.51B |
| Kwality Pharmaceuticals | 22.15B |
| Amrutanjan Health Care | 16.14B |
| Lincoln Pharmaceuticals | 14.69B |